PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling in vivo and in vitro - Lin, Jiancheng; Pan, Zetao; Sun, Jiayan; Wang, Xiaowan; Yin, Di; Huo, Cunyang; Guo, Qiang (Frontiers in Medicine, 2024)